Biotechnology Earnings Summary: Moderna swings to profit in Q3 on modest revenue growth 2 weeks ago Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported net income for the third quarter of 2024, compared to a loss… Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results 3 weeks ago Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9… Key highlights from Biogen’s (BIIB) Q3 2024 earnings results 3 weeks ago Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion.… Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights 1 month ago Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion.… TRxADE Health changes its name to Scienture Holdings 2 months ago Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that… IPO News: Everything you need to know about BioAge Labs’ IPO 2 months ago BioAge Labs, Inc. is the latest among the healthcare companies pursuing stock-market listing this year. In a registration statement filed… Ocean Biomedical (NASDAQ: OCEA) Research Summary 3 months ago Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new therapeutic candidates efficiently from the laboratory… Trxade Health (MEDS) Q2 2024 Research Summary 3 months ago Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry… MEDS Earnings: A snapshot of Trxade’s Q2 2024 results 3 months ago Health services IT company Trxade Health, Inc. (NASDAQ: MEDS) announced financial results for the second quarter of 2024, reporting a… Earnings Summary: Gilead Sciences reports higher Q2 revenue and profit 3 months ago Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, has reported an increase in revenues and adjusted earnings for… LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report 4 months ago Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter… Earnings Summary: Moderna reports Q2 2024 financial results 4 months ago Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported a sharp decline in revenues for the second quarter of 2024. Second-quarter… Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat 4 months ago Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted… BMY Earnings: Bristol-Myers Squibb reports higher Q2 revenue and profit 4 months ago Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported higher revenues and net profit for the second quarter of 2024.… Everything you need to know about OS Therapies’ upcoming IPO 5 months ago There has been a strong uptick in IPO activity this year compared to 2023 when the market witnessed a slowdown.… Alumis looks to raise $300 million in IPO. Here’s what you need to know 5 months ago Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared… Ocean Biomedical (NASDAQ: OCEA) Research Summary 6 months ago Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology firm that works to accelerate the development of new therapies by… Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24 7 months ago The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in… Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results 7 months ago Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined… MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth 7 months ago Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of… BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues 7 months ago Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite… Next»